Clinical Trials
It is a core value for TOOsonix to commit to developing new and innovative treatment modalities in cooperation with leading university hospitals and clinical partners.
Below is a list of on-going clinical trials aimed at developing groundbreaking clinical data that can expand the approved medical use of our products.
Active
HIFU Treatment of Cutaneous Neurofibromas in Neurofibromatosis Type 1: Safety and Efficacy (cNF-HFU2101)
Objective:
Demonstrate safety and efficacy of HIFU treatment of cutaneous neurofibromas located close to the surface of the skin in patients with the genetic disease Neurofibromatosis Type 1. The study will use a new investigational equipment that has been specially developed for dermatological therapy.
Location:
Bispebjerg University Hospital, Copenhagen Denmark
Sahlgrenska University Hospital, Gothenburg Sweden
Active
HIFU for Treatment of Non-nodular and Recurrent BCC (BCC-HIFU2101)
Objective:
Demonstrate the safety and efficacy of removal of Basal Cell Carcinoma (BCC) using a new investigational equipment based on high-intensity focused ultrasound.
Locations:
Bispebjerg University Hospital, Copenhagen Denmark
Zealand University Hospital, Roskilde Denmark
Active
High Intensity Focused Ultrasound (HIFU) Treatment of Basal Cell Carcinoma (HIFU-BCC)
Objective:
Evaluate the safety and efficacy of treatment of Basal Cell Carcinoma (BCC) using a new modality based on high-intensity focused ultrasound (HIFU).
Location:
Old Town Clinic, Wroclaw Poland